Allodynia and hyperalgesia induced by herpes simplex virus type-1 infection in mice
- PMID: 10779666
- DOI: 10.1016/s0304-3959(00)00240-2
Allodynia and hyperalgesia induced by herpes simplex virus type-1 infection in mice
Abstract
Human subjects infected with herpes or varicella-zoster viruses complain of pain, such as allodynia, in or near the region with vesicles. However, the mechanisms of the pain are unclear. We show for the first time that infection with herpes simplex virus type-1 (HSV-1) induces allodynia and hyperalgesia in mice. When HSV-1 was inoculated on the hind paw of the mouse, eruption appeared on the back on day 5 post-inoculation, and zosteriform skin lesions were developed on the inoculated side. Allodynia and hyperalgesia became apparent in the hind paw on the inoculated side on day 5 and persisted until at least day 8. HSV-1 DNA was detected in the dorsal root ganglia from days 2 to 8 post-inoculation, with a peak effect on day 5. The application of heat-inactivated HSV-1 induced no allodynia, hyperalgesia and skin lesion. When started from days 0 or 2, repeated treatment with acyclovir, anti-HSV-1 agent, inhibited the appearance of allodynia, hyperalgesia, eruption and the viral proliferation in the dorsal root ganglia. In contrast, when started from days 5 or 6, acyclovir treatment slightly inhibited the development of skin lesions and the viral proliferation, but not allodynia and hyperalgesia. These results suggest that the propagation of HSV-1 in the dorsal root ganglia produces allodynia and hyperalgesia as a result of functional abnormality of the sensory neurons in mice. This may be a useful model for studying the mechanisms of herpetic pain.
Similar articles
-
Pharmacological and immunohistochemical characterization of a mouse model of acute herpetic pain.Jpn J Pharmacol. 2000 Aug;83(4):319-26. doi: 10.1254/jjp.83.319. Jpn J Pharmacol. 2000. PMID: 11001178
-
Pharmacological differences between static and dynamic allodynia in mice with herpetic or postherpetic pain.J Pharmacol Sci. 2008 Nov;108(3):266-73. doi: 10.1254/jphs.08154fp. Epub 2008 Nov 6. J Pharmacol Sci. 2008. PMID: 18987431
-
Paresthesia induced by cutaneous infection with herpes simplex virus in rats.Neurosci Lett. 1995 May 5;190(2):101-4. doi: 10.1016/0304-3940(95)11512-u. Neurosci Lett. 1995. PMID: 7644115
-
[Battle with herpes for 37 years].Nippon Ganka Gakkai Zasshi. 2015 Mar;119(3):145-66; discussion 167. Nippon Ganka Gakkai Zasshi. 2015. PMID: 25854108 Review. Japanese.
-
Activation of Herpes Simplex Infection after Tattoo.Acta Dermatovenerol Croat. 2018 Apr;26(1):75-76. Acta Dermatovenerol Croat. 2018. PMID: 29782308 Review.
Cited by
-
Rodent models of postherpetic neuralgia: How far have we reached?Front Immunol. 2023 Mar 20;14:1026269. doi: 10.3389/fimmu.2023.1026269. eCollection 2023. Front Immunol. 2023. PMID: 37020565 Free PMC article. Review.
-
Kappa opioids and the modulation of pain.Psychopharmacology (Berl). 2010 Jun;210(2):109-19. doi: 10.1007/s00213-010-1819-6. Epub 2010 Apr 7. Psychopharmacology (Berl). 2010. PMID: 20372880 Review.
-
TRPV1-target drugs for the treatment of orofacial pain.Front Pharmacol. 2025 Apr 24;16:1568109. doi: 10.3389/fphar.2025.1568109. eCollection 2025. Front Pharmacol. 2025. PMID: 40343000 Free PMC article. Review.
-
A novel P2X4 receptor-selective antagonist produces anti-allodynic effect in a mouse model of herpetic pain.Sci Rep. 2016 Aug 31;6:32461. doi: 10.1038/srep32461. Sci Rep. 2016. PMID: 27576299 Free PMC article.
-
Nociceptive signaling of P2X receptors in chronic pain states.Purinergic Signal. 2021 Mar;17(1):41-47. doi: 10.1007/s11302-020-09743-w. Epub 2020 Oct 5. Purinergic Signal. 2021. PMID: 33015745 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical